LabTech launches MicroStreak in US
Wednesday, 11 June, 2008
Adelaide-based diagnostics company LabTech Systems (ASX: LBT) has launched its MicroStreak technology in the US.
The company held a launch for the product, which has been named PREVI Isola by licensees bioMerieux, at the American Society of Microbiology meeting held in Boston this week.
MicroStreak is a new method of microbiology processing, automating the streaking of agar plates to test samples. The technology was already launched in Europe in April.
LabTech has earned $4.9 million in licence fees to date.
For a full report on the MicroStreak, see the July/August edition of Australian Life Scientist.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
